VentriPoint Diagnostics Ltd.  

(Public, CVE:VPT)   Watch this stock  
Find more results for VPT
0.0000 (0.00%)
Delayed:   10:19AM EDT
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.05 - 0.05
52 week 0.04 - 0.09
Open 0.05
Vol / Avg. 104,000.00/173,475.00
Mkt cap 10.13M
P/E     -
Div/yield     -
EPS -0.01
Shares 202.60M
Beta 0.61
Inst. own     -


100 W Harrison St Ste 410
SEATTLE, WA 98119-4116
United States - Map
+1-206-2830221 (Phone)
+1-425-7474163 (Fax)

Website links


VentriPoint Diagnostics Ltd (VentriPoint) is a medical device company engaged in the development and commercialization of its diagnostic tools to monitor patients with heart disease. By using images produced from existing medical imaging systems, the Ventripoint Medical System (VMS) generates right heart volumetric measurements and a three dimensional model. The VMS enables medical professionals to obtain three-dimensional models with critical volume and functional measurements of a patient’s right ventricle. Ventripoint’s solution produces critical heart information by processing standard information received from existing medical imaging equipment with its methods incorporating Knowledge Based Reconstruction (KBR) algorithms and cardiac databases. The Company’s KBR method allows for the creation of a three-dimensional model of the right and/or left ventricle using images generated from existing 2D imaging equipment.

Officers and directors

Treuman P. Katz Independent Chairman of the Board
George Adams President, Chief Executive Officer, Director
Ellen Briant Chief Financial Officer
Alan Rabinowitz Director
Danny Dalla-Longa Independent Director